The development & approval of Novoeight, a case study
Rasagiline
BIO-ARTIFICIAL LIVER
Emrat e Barnave
Emrat e Barnave 1
Emrat e Barnave 2
China Blood Product Industry Report, 2015-2018
Erythropoietin 2
Dirk Himpe MD PhD MHE EDIC ZNA Middelheim General Hospital Antwerp Belgium Prime Time ! Fluids during Cardiac Surgery.
Key Area: 2 Therapeutic uses of cells Unit 1: Cell Biology.
The SAFE Study (Saline v Albumin Fluid Evaluation) Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood.
CELL-BASED MYOGENIC AND ANGIOGENIC THERAPY FOR MYOCARDIAL REGENERATION J.C. CHACHQUES, MD, PhD POMPIDOU HOSPITAL PARIS - FRANCE.
